GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease

Heterozygous mutations in the GBA gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), are the strongest known genetic risk factor for Parkinson’s disease (PD). The molecular mechanisms underlying the increased PD risk and the variable phenotypes observed in carriers of different GBA muta...

Full description

Bibliographic Details
Main Authors: Silvia Cerri, Cristina Ghezzi, Gerardo Ongari, Stefania Croce, Micol Avenali, Roberta Zangaglia, Donato A. Di Monte, Enza Maria Valente, Fabio Blandini
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/4/2215
id doaj-52c40c1c184842408f263b511aae77f4
record_format Article
spelling doaj-52c40c1c184842408f263b511aae77f42021-02-24T00:04:38ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-02-01222215221510.3390/ijms22042215GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s DiseaseSilvia Cerri0Cristina Ghezzi1Gerardo Ongari2Stefania Croce3Micol Avenali4Roberta Zangaglia5Donato A. Di Monte6Enza Maria Valente7Fabio Blandini8Cellular and Molecular Neurobiology Unit, IRCCS Mondino Foundation, 27100 Pavia, ItalyCellular and Molecular Neurobiology Unit, IRCCS Mondino Foundation, 27100 Pavia, ItalyCellular and Molecular Neurobiology Unit, IRCCS Mondino Foundation, 27100 Pavia, ItalyDepartment of General Surgery, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyDepartment of Brain and Behavioural Sciences, University of Pavia, 27100 Pavia, ItalyParkinson’s Disease and Movement Disorders Unit, IRCCS Mondino Foundation, 27100 Pavia, ItalyGerman Centre for Neurodegenerative Diseases (DZNE), 53175 Bonn, GermanyNeurogenetics Research Center, IRCCS Mondino Foundation, 27100 Pavia, ItalyCellular and Molecular Neurobiology Unit, IRCCS Mondino Foundation, 27100 Pavia, ItalyHeterozygous mutations in the GBA gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), are the strongest known genetic risk factor for Parkinson’s disease (PD). The molecular mechanisms underlying the increased PD risk and the variable phenotypes observed in carriers of different GBA mutations are not yet fully elucidated. Extracellular vesicles (EVs) have gained increasing importance in neurodegenerative diseases since they can vehiculate pathological molecules potentially promoting disease propagation. Accumulating evidence showed that perturbations of the endosomal–lysosomal pathway can affect EV release and composition. Here, we investigate the impact of GCase deficiency on EV release and their effect in recipient cells. EVs were purified by ultracentrifugation from the supernatant of fibroblast cell lines derived from PD patients with or without GBA mutations and quantified by nanoparticle tracking analysis. SH-SY5Y cells over-expressing alpha-synuclein (α-syn) were used to assess the ability of patient-derived small EVs to affect α-syn expression. We observed that defective GCase activity promotes the release of EVs, independently of mutation severity. Moreover, small EVs released from PD fibroblasts carrying severe mutations increased the intra-cellular levels of phosphorylated α-syn. In summary, our work shows that the dysregulation of small EV trafficking and alpha-synuclein mishandling may play a role in GBA-associated PD.https://www.mdpi.com/1422-0067/22/4/2215Parkinson’s diseaseglucocerebrosidaseextracellular vesiclesalpha-synucleinGBA mutationslipids
collection DOAJ
language English
format Article
sources DOAJ
author Silvia Cerri
Cristina Ghezzi
Gerardo Ongari
Stefania Croce
Micol Avenali
Roberta Zangaglia
Donato A. Di Monte
Enza Maria Valente
Fabio Blandini
spellingShingle Silvia Cerri
Cristina Ghezzi
Gerardo Ongari
Stefania Croce
Micol Avenali
Roberta Zangaglia
Donato A. Di Monte
Enza Maria Valente
Fabio Blandini
GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
International Journal of Molecular Sciences
Parkinson’s disease
glucocerebrosidase
extracellular vesicles
alpha-synuclein
GBA mutations
lipids
author_facet Silvia Cerri
Cristina Ghezzi
Gerardo Ongari
Stefania Croce
Micol Avenali
Roberta Zangaglia
Donato A. Di Monte
Enza Maria Valente
Fabio Blandini
author_sort Silvia Cerri
title GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
title_short GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
title_full GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
title_fullStr GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
title_full_unstemmed GBA Mutations Influence the Release and Pathological Effects of Small Extracellular Vesicles from Fibroblasts of Patients with Parkinson’s Disease
title_sort gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-02-01
description Heterozygous mutations in the GBA gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), are the strongest known genetic risk factor for Parkinson’s disease (PD). The molecular mechanisms underlying the increased PD risk and the variable phenotypes observed in carriers of different GBA mutations are not yet fully elucidated. Extracellular vesicles (EVs) have gained increasing importance in neurodegenerative diseases since they can vehiculate pathological molecules potentially promoting disease propagation. Accumulating evidence showed that perturbations of the endosomal–lysosomal pathway can affect EV release and composition. Here, we investigate the impact of GCase deficiency on EV release and their effect in recipient cells. EVs were purified by ultracentrifugation from the supernatant of fibroblast cell lines derived from PD patients with or without GBA mutations and quantified by nanoparticle tracking analysis. SH-SY5Y cells over-expressing alpha-synuclein (α-syn) were used to assess the ability of patient-derived small EVs to affect α-syn expression. We observed that defective GCase activity promotes the release of EVs, independently of mutation severity. Moreover, small EVs released from PD fibroblasts carrying severe mutations increased the intra-cellular levels of phosphorylated α-syn. In summary, our work shows that the dysregulation of small EV trafficking and alpha-synuclein mishandling may play a role in GBA-associated PD.
topic Parkinson’s disease
glucocerebrosidase
extracellular vesicles
alpha-synuclein
GBA mutations
lipids
url https://www.mdpi.com/1422-0067/22/4/2215
work_keys_str_mv AT silviacerri gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT cristinaghezzi gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT gerardoongari gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT stefaniacroce gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT micolavenali gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT robertazangaglia gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT donatoadimonte gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT enzamariavalente gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
AT fabioblandini gbamutationsinfluencethereleaseandpathologicaleffectsofsmallextracellularvesiclesfromfibroblastsofpatientswithparkinsonsdisease
_version_ 1724253579275927552